BG
NXTM

BlackRock Group’s NxStage Medical Inc. NXTM Stock Holding History

BlackRock Group’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.07M Buy
78,879
+3,401
+5% +$84.1K ﹤0.01% 1747
2016
Q3 		$1.89M Buy
75,478
+1,458
+2% +$34K ﹤0.01% 1667
2016
Q2 		$1.6M Buy
74,020
+5,273
+8% +$94.1K ﹤0.01% 1686
2016
Q1 		$1.03M Buy
68,747
+7,176
+12% +$120K ﹤0.01% 1933
2015
Q4 		$1.35M Sell
61,571
-328
-0.5% -$6.11K ﹤0.01% 1709
2015
Q3 		$976K Buy
61,899
+28,917
+88% +$464K ﹤0.01% 1896
2015
Q2 		$472K Buy
32,982
+2,050
+7% +$34.7K ﹤0.01% 2289
2015
Q1 		$535K Buy
30,932
+1,188
+4% +$21K ﹤0.01% 2166
2014
Q4 		$533K Buy
29,744
+10,218
+52% +$165K ﹤0.01% 2204
2014
Q3 		$256K Hold
19,526
– – ﹤0.01% 2382
2014
Q2 		$280K Sell
19,526
-19,325
-50% -$252K ﹤0.01% 2372
2014
Q1 		$495K Hold
38,851
– – ﹤0.01% 2241
2013
Q4 		$388K Buy
38,851
+3,530
+10% +$40.1K ﹤0.01% 2284
2013
Q3 		$464K Hold
35,321
– – ﹤0.01% 2253
2013
Q2 		$504K Buy
+35,321
New +$444K ﹤0.01% 2053

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Group's NXTM Position: Q4 2016 in Review

BlackRock Group increased its NxStage Medical Inc. (NXTM) stake by 4.5% in Q4 2016, buying an estimated $84.1K and bringing the position to 78,879 shares worth $2.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1747.

BlackRock Group first reported a position in NXTM in Q2 2013 and has held it in 15 quarters since. 170 funds tracked by Wall St. Rank hold NXTM as of Q4 2016.

  • BlackRock Group held 78,879 shares of NxStage Medical Inc. worth $2.07M as of Q4 2016.
  • BlackRock Group bought 3,401 NxStage Medical Inc. shares in Q4 2016, an estimated $84.1K.
  • NxStage Medical Inc. made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1747 holding.
  • BlackRock Group first reported a position in NxStage Medical Inc. in Q2 2013 and has held it in 15 quarters since.
  • 170 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.